• 12283 Citations
  • 39 h-Index
1973 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1973 2019

  • 12283 Citations
  • 39 h-Index
  • 217 Article
  • 2 Chapter
  • 1 Editorial
Filter
Article
Article

A biszfo szfo nát-keze lés során és zlelhet o vese funkci ó-válto zás vizsg álata emlorákos betege inknél

Translated title of the contribution: Changes in renal function during bisphosphonate treatment of breast cancer patientsHorváth, Z., Farkas, P., Ganofszky, E., Hitre, E., Juhos, É., Nagy, T., Rubovszky, G., Szabó, E. & Láng, I., 2008, In : Magyar Onkologia. 52, 1, p. 49-55 7 p.

Research output: Contribution to journalArticle

Diphosphonates
Breast Neoplasms
Kidney
Creatinine
Therapeutics
63 Citations (Scopus)

Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials

Regan, M. M., Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Viale, G., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Pinotti, G., Price, K. N., Coates, A. S., Goldhirsch, A. & Gelber, R. D., Jul 1 2016, In : Journal of Clinical Oncology. 34, 19, p. 2221-2230 10 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Hormones
Breast Neoplasms
Therapeutics
10 Citations (Scopus)

A Case-Control Study of Gallbladder Cancer in Hungary

Nakadaira, H., Láng, I., Szentirmay, Z., Hitre, E., Kaster, M. & Yamamoto, M., 2009, In : Asian Pacific Journal of Cancer Prevention. 10, 5, p. 833-836 4 p.

Research output: Contribution to journalArticle

Gallbladder Neoplasms
Capsicum
Hungary
Case-Control Studies
Gallstones

A colorectalis carcinoma irinotecan kezelésének legújabb eredményei

Translated title of the contribution: Novel data on the irinotecan treatment of colorectal cancerLáng, I. & Hitre, E., 2004, In : Magyar Onkologia. 48, 4, p. 281-288 8 p.

Research output: Contribution to journalArticle

irinotecan
oxaliplatin
Colorectal Neoplasms
Fluorouracil
Therapeutics
3 Citations (Scopus)

A colorectalis carcinoma irinotecan kezelésének legújabb eredményei.

Translated title of the contribution: Recent results of irinotecan therapy in colorectal cancerLáng, I. & Hitre, E., 2004, In : Magyar Onkologia. 48, 4, p. 281-288 8 p.

Research output: Contribution to journalArticle

irinotecan
oxaliplatin
Colorectal Neoplasms
Fluorouracil
Therapeutics
3 Citations (Scopus)

A comparative analysis on the efficacy and safety of intaxelspi® and taxolspi® in advanced metastatic breast cancer

Láng, I., Rubovszky, G., Horváth, Z., Ganofszky, E., Szabó, E., Dank, M., Boer, K. & Hitre, E., Jun 1 2013, In : Journal of Clinical and Diagnostic Research. 7, 6, p. 1120-1124 5 p.

Research output: Contribution to journalArticle

Paclitaxel
Breast Neoplasms
Safety
Carboplatin
Doxorubicin

Action of cyclic nucleotides in antibody dependent cellular cytotoxicity reactions

Láng, I., Kalmar, L. & Gergely, P., 1978, In : Kiserletes Orvostudomany. 30, 3, p. 300-305 6 p.

Research output: Contribution to journalArticle

Cyclic Nucleotides
Antibodies

Activity tests on concanavalin A-induced suppressor cells in autologous and allogenous systems

Gergely, P., Gonzalez Cabello, R., Láng, I. & Kalmar, L., 1980, In : Kiserletes Orvostudomany. 32, 5, p. 514-518 5 p.

Research output: Contribution to journalArticle

Concanavalin A
13 Citations (Scopus)

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Láng, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno-Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & de Azambuja, E., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 86-94 9 p.

Research output: Contribution to journalArticle

Amenorrhea
Breast Neoplasms
Survival
Hormones
Therapeutics
124 Citations (Scopus)

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial

Francis, P., Crown, J., Di Leo, A., Buyse, M., Balil, A., Andersson, M., Nordenskjöld, B., Láng, I., Jakesz, R., Vorobiof, D., Gutiérrez, J., Van Hazel, G., Dolci, S., Jamin, S., Bendahmane, B., Gelber, R. D., Goldhirsch, A., Castiglione-Gertsch, M. & Piccart-Gebhart, M., Jan 2008, In : Journal of the National Cancer Institute. 100, 2, p. 121-133 13 p.

Research output: Contribution to journalArticle

docetaxel
Anthracyclines
Adjuvant Chemotherapy
Breast
Doxorubicin
300 Citations (Scopus)

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., Ciruelos, E., Stearns, V., Bonnefoi, H. R., Martino, S., Geyer, C. E., Pinotti, G., Puglisi, F., Crivellari, D., Ruhstaller, T., Winer, E. P. & 13 others, Rabaglio-Poretti, M., Maibach, R., Ruepp, B., Giobbie-Hurder, A., Price, K. N., Bernhard, J., Luo, W., Ribi, K., Viale, G., Coates, A. S., Gelber, R. D., Goldhirsch, A. & Francis, P. A., 2014, In : New England Journal of Medicine. 371, 2, p. 107-118 12 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms
Triptorelin Pamoate
168 Citations (Scopus)

Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial

Piccart-Gebhart, M., Holmes, E., Baselga, J., De Azambuja, E., Dueck, A. C., Viale, G., Zujewski, J. A., Goldhirsch, A., Armour, A., Pritchard, K. I., McCullough, A. E., Dolci, S., McFadden, E., Holmes, A. P., Tonghua, L., Eidtmann, H., Dinh, P., Di Cosimo, S., Harbeck, N., Tjulandin, S. & 15 others, Im, Y. H., Huang, C. S., Díeras, V., Hillman, D. W., Wolff, A. C., Jackisch, C., Láng, I., Untch, M., Smith, I., Boyle, F., Xu, B., Gomez, H., Suter, T., Gelber, R. D. & Perez, E. A., Apr 1 2016, In : Journal of Clinical Oncology. 34, 10, p. 1034-1042 9 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Breast Neoplasms
Epidermal Growth Factor
Medical Futility
Therapeutics
304 Citations (Scopus)

Adjuvant ovarian suppression in premenopausal breast cancer

Francis, P. A., Regan, M. M., Fleming, G. F., Láng, I., Ciruelos, E., Bellet, M., Bonnefoi, H. R., Climent, M. A., Da Prada, G. A., Burstein, H. J., Martino, S., Davidson, N. E., Geyer, C. E., Walley, B. A., Coleman, R., Kerbrat, P., Buchholz, S., Ingle, J. N., Winer, E. P. M., Rabaglio-Poretti, M. & 9 others, Maibach, R., Ruepp, B., Giobbie-Hurder, A., Price, K. N., Colleoni, M., Viale, G., Coates, A. S., Goldhirsch, A. & Gelber, R. D., Jan 1 2015, In : New England Journal of Medicine. 372, 5, p. 436-446 11 p.

Research output: Contribution to journalArticle

Tamoxifen
Breast Neoplasms
exemestane
Recurrence
Confidence Intervals
27 Citations (Scopus)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a " standard chemotherapy regimen": The CASA randomized trial

Crivellari, D., Gray, K. P., Dellapasqua, S., Puglisi, F., Ribi, K., Price, K. N., Láng, I., Gianni, L., Spazzapan, S., Pinotti, G., Lüthi, J. M., Gelber, R. D., Regan, M. M., Colleoni, M., Castiglione-Gertsch, M., Maibach, R., Rabaglio, M., Coates, A. S. & Goldhirsch, A., Apr 2013, In : Breast. 22, 2, p. 130-137 8 p.

Research output: Contribution to journalArticle

Methotrexate
Cyclophosphamide
Breast Neoplasms
Drug Therapy
Progesterone Receptors
310 Citations (Scopus)

Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer

Von Minckwitz, G., Procter, M., De Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., Knott, A., Lang, I., Levy, C., Yardley, D. A., Bines, J., Gelber, R. D., Piccart, M. & Baselga, J., Jul 13 2017, In : New England Journal of Medicine. 377, 2, p. 122-131 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Placebos
Disease-Free Survival
Confidence Intervals
Adjuvant Chemotherapy
11 Citations (Scopus)

Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC).

Boér, K., Láng, I., Juhos, E., Pintér, T. & Szántó, J., 2003, In : Pathology and Oncology Research. 9, 3, p. 166-169 4 p.

Research output: Contribution to journalArticle

docetaxel
Doxorubicin
Cyclophosphamide
Fluorouracil
Breast Neoplasms
1 Citation (Scopus)

A gastrointestinalis stroma tumorok (GIST) kezelésének modern szemlélete

Translated title of the contribution: Modern aspects of the treatment of gastrointestinal stromal tumors (GIST)Láng, I. & Hitre, E., 2005, In : Orvosi Hetilap. 146, 18 SUPPL.1, p. 935-941 7 p.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Clinical Trials
Therapeutics
Protein-Tyrosine Kinases
Neoplasms

A hanging manover újabb indikációi a májsebészetben.

Translated title of the contribution: [Latest indications for hanging manoeuvre in liver surgery].Jakab, F., Dede, K., Láng, I., Bursics, A. & Mersich, T., Dec 2012, In : Magyar sebészet. 65, 6, p. 407-415 9 p.

Research output: Contribution to journalArticle

Liver
Venae Cavae
Inferior Vena Cava
Neoplasms
Safety

A hasnyálmirigyrák kemoterápiája.

Translated title of the contribution: Chemotherapy in pancreatic cancerLáng, I., Feb 1 2004, In : Orvosi Hetilap. 145, 5, p. 239-242 4 p.

Research output: Contribution to journalArticle

Antineoplastic Antimetabolites
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine
Neoadjuvant Therapy
Adjuvant Chemotherapy

A humán antitest-dependens celluláris cytotoxicitás (ADCC) vizsgálata allogén rendszerben.

Translated title of the contribution: Study of human antibody-dependent cellular cytotoxicity (ADCC) in an allogenic systemLáng, I., Fekete, B., Gergely, P. & Petrányi, G., Jul 24 1977, In : Orvosi Hetilap. 118, 30, p. 1763-1765 3 p.

Research output: Contribution to journalArticle

Immunologic Cytotoxicity Tests
Rh-Hr Blood-Group System
Lymphoid Leukemia
Lymphocyte Activation
Antibody Formation

A keringö daganatsejtek és a mikrometasztázisok kimutatása molekuláris biológiai módszerekkel.

Translated title of the contribution: Biologic detection methods in the comparison of circulating tumor cells and micrometastasesDombóvári, Z., Molnár, B., Bocsi, J., Láng, I., Papik, K., Fehér, J. & Tulassay, Z., Jul 26 1998, In : Orvosi Hetilap. 139, 30, p. 1793-1797 5 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Neoplasm Micrometastasis
Reverse Transcriptase Polymerase Chain Reaction
Neoplasms
Molecular Pathology

A májmetasztázisok sebészete az uj evezred küszöbén.

Translated title of the contribution: Surgical treatment of colorectal liver metastasis in the year 2000Jakab, F., Mersich, T. & Láng, I., 2004, In : Magyar sebészet. 57, 1, p. 3-11 9 p.

Research output: Contribution to journalArticle

Neoplasm Metastasis
Liver
Therapeutics
Survival Rate
Drug Therapy
3 Citations (Scopus)

A metiléntetrahidrofolát-reduktáz (MTHFR) C677T polimorfizmus klinikai jelento{double acute}sége a metasztatikus colorectalis daganatok 5-fluoropirimidin-alapú kezelésében

Barna, B., Hitre, E., Vilmos, A., Ferenc, C., Fruzsina, G., Láng, I. & Judit, K., 2004, In : Magyar Onkologia. 48, 3, p. 253-257 5 p.

Research output: Contribution to journalArticle

A metiléntetrahidrofolát-reduktáz (MTHFR) C677T polimorfizmus klinikai jelentôsége a metasztatikus colorectalis daganatok 5-fluoropirimidin-alapú kezelésében.

Translated title of the contribution: The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of metastatic colorectal tumoursBudai, B., Hitre, E., Adleff, V., Czeglédi, F., Gyergyay, F., Láng, I. & Kralovánszky, J., 2004, In : Magyar Onkologia. 48, 3, p. 253-257 5 p.

Research output: Contribution to journalArticle

Methylenetetrahydrofolate Reductase (NADPH2)
Colorectal Neoplasms
Genotype
Therapeutics
Survival
8 Citations (Scopus)

A modern emlo{double acute}sebészet onkoplasztikai kihívásai

Translated title of the contribution: Oncoplastic challenges in modern breast surgeryMátrai, Z., Gulyás, G., Tóth, L., Polgár, C., Bidlek, M., Szabó, É., Láng, I., Horváth, Z., Udvarhelyi, N., Kunos, C., Sávolt, Á., Pesthy, P. & Kásler, M., 2011, In : Magyar Onkologia. 55, 1, p. 40-52 13 p.

Research output: Contribution to journalArticle

Breast
Mammaplasty
Esthetics
Neoplasms
Breast Neoplasms
97 Citations (Scopus)

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study

Colleoni, M., Giobbie-Hurder, A., Regan, M. M., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Láng, I., Smith, I., Chirgwin, J., Pienkowski, T., Wardley, A., Price, K. N., Gelber, R. D., Coates, A. S. & Goldhirsch, A., Mar 20 2011, In : Journal of Clinical Oncology. 29, 9, p. 1117-1124 8 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Breast
Survival
Disease-Free Survival
16 Citations (Scopus)

Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience

Metzger-Filho, O., de Azambuja, E., Bradbury, I., Saini, K. S., Bines, J., Simon, S. D., van Dooren, V., Aktan, G., Pritchard, K. I., Wolff, A. C., Smith, I., Jackisch, C., Láng, I., Untch, M., Boyle, F., Xu, B., Baselga, J., Perez, E. A. & Piccart-Gebhart, M., 2013, In : Oncologist. 18, 2, p. 134-140 7 p.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Breast Neoplasms
Ethics Committees
Research Ethics Committees
Therapeutics
2 Citations (Scopus)

Antibody-dependent and spontaneous cell-mediated cytotoxicity in children with acute lymphoblastic leukemia

Lang, I., Zoltan, E., Revesz, T., Gergely, P., Schuler, D. & Petranyi, G., 1982, In : Allergologia et Immunopathologia. 10, 5, p. 341-345 5 p.

Research output: Contribution to journalArticle

Immunologic Cytotoxicity
Immunologic Cytotoxicity Tests
Immunologic Surveillance
Antibody-Dependent Cell Cytotoxicity
Lymphoid Leukemia
6 Citations (Scopus)

Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects, patients with SLE, and malignancies

Lang, I., Benczur, M., Varga, M., Gergely, P. & Petrányi, G., 1977, In : Acta Medica Academiae Scientiarum Hungaricae. 34, 3, p. 123-127 5 p.

Research output: Contribution to journalArticle

Lymphocytes
Systemic Lupus Erythematosus
Antibodies
Chickens
Healthy Volunteers
4 Citations (Scopus)

Antibody-dependent cellular cytocoxicity in systemic lupus erythematosus

Láng, I., Fekete, B., Pálóczi, K., Sonkoly, I., Szegedi, G., Török, K., Gergely, P. & Petrányi, G., 1977, In : Acta Medica Academiae Scientiarum Hungaricae. 34, 4, p. 259-265 7 p.

Research output: Contribution to journalArticle

Antibody-Dependent Cell Cytotoxicity
Systemic Lupus Erythematosus
Lymphocytes
Antibodies

Antibody-dependent cellular cytotoxic activity in patients with Hodgkin disease

Láng, I., Berenyi, E., Szegedi, G., Török, K., Fekete, B. & Gergely, P., 1977, In : Acta Medica Academiae Scientiarum Hungaricae. 34, 4, p. 241-245 5 p.

Research output: Contribution to journalArticle

Antibody-Dependent Cell Cytotoxicity
Rosette Formation
Hodgkin Disease
Immunoglobulins
Erythrocytes
4 Citations (Scopus)

Antibody dependent cellular cytotoxicity of lymphocytes in patients with renal diseases of immunopathological origin

Láng, I., Kenez, B., Nagy, Z. K., Sonkoly, I., Pálóczi, K., Szegedi, G., Fekete, B. & Gergely, P., 1978, In : Clinical Nephrology. 9, 3, p. 111-114 4 p.

Research output: Contribution to journalArticle

Lymphocytes
Kidney
Antibodies
Glomerulonephritis
Erythrocytes
1 Citation (Scopus)

A pet/ct szerepe az emlörák diagnosztikájában és kezelésében - összefoglaló az eddig megszerzett ismeretekrõl és a kutatás további irányairól

Translated title of the contribution: Role of PET/CT in diagnosis and treatment of breast cancer - Review on present knowledge and current research trendsBalázs, M., Horváth, Z., Láng, I., Kásler, M. & Katalin, B., 2012, In : Magyar Onkologia. 56, 1, p. 23-29 7 p.

Research output: Contribution to journalArticle

Positron-Emission Tomography
Breast Neoplasms
Research
Neoplasms
Lymph Nodes
93 Citations (Scopus)

A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens

Bennouna, J., Láng, I., Valladares-Ayerbes, M., Boer, K., Adenis, A., Escudero, P., Kim, T. Y., Pover, G. M., Morris, C. D. & Douillard, J. Y., Oct 2011, In : Investigational New Drugs. 29, 5, p. 1021-1028 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Safety
Disease-Free Survival
Disease Progression
oxaliplatin
4 Citations (Scopus)

A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer

Dittrich, C., Solska, E., Manikhas, A., Eniu, A., Tjulandin, S., Anghel, R., Musib, L., Frimodt-Moller, B., Liu, Y., Krejcy, K. & Láng, I., May 2012, In : Cancer Investigation. 30, 4, p. 309-316 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Cyclophosphamide
Multicenter Studies
Breast Neoplasms
Disease-Free Survival
82 Citations (Scopus)

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

Martin, M., Bonneterre, J., Geyer, C. E., Ito, Y., Ro, J., Láng, I., Kim, S. B., Germa, C., Vermette, J., Wang, K., Wang, K. & Awada, A., Dec 2013, In : European Journal of Cancer. 49, 18, p. 3763-3772 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Disease-Free Survival
Capecitabine
lapatinib

A simple allogeneic test system for the study of antibody-dependent cellular cytotoxicity (ADCC) in man.

Láng, I., Fekete, B., Gergely, P. & Petrányi, G., 1977, In : Haematologia. 11, 1-2, p. 85-91 7 p.

Research output: Contribution to journalArticle

Antibodies
Leukocytes
Wool
Nylons
Human Activities
258 Citations (Scopus)

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: The BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Regan, M. M., Neven, P., Giobbie-Hurder, A., Goldhirsch, A., Ejlertsen, B., Mauriac, L., Forbes, J. F., Smith, I., Láng, I., Wardley, A., Rabaglio, M., Price, K. N., Gelber, R. D., Coates, A. S. & Thürlimann, B., Nov 2011, In : The Lancet Oncology. 12, 12, p. 1101-1108 8 p.

Research output: Contribution to journalArticle

letrozole
Steroid Receptors
Tamoxifen
Randomized Controlled Trials
Hormones
4 Citations (Scopus)

A tripla-negatív emlokarcinóma - Irodalmi áttekintés

Translated title of the contribution: Triple negative breast carcinoma - Rewiev of current literatureRubovszky, G., Udvarhelyi, N., Horváth, Z., Láng, I. & Kásler, M., Dec 1 2010, In : Magyar Onkologia. 54, 4, p. 325-335 11 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Breast Neoplasms
Publications
Research Personnel
Neoplasm Genes
2 Citations (Scopus)

Az amiodaron által elöidézett oxidativ stresszállapot szerepe a gyógyszer mellékhatásaiban.

Translated title of the contribution: The role of oxidative stress, caused by amiodarone, in the side effects of the drugVereckei, A., Blázovics, A., Szénási, G., Kónya, L., Láng, I., Zsinka, A. & Fehér, J., Mar 3 1991, In : Orvosi Hetilap. 132, 9, p. 483-484, 487

Research output: Contribution to journalArticle

Amiodarone
Drug-Related Side Effects and Adverse Reactions
Oxidative Stress
Lipid Peroxidation
Free Radicals
12 Citations (Scopus)

Az emloárák belgyógyászati onkológiai (gyógyszeres) kezelése

Láng, I., Kahán, Z., Pintér, T., Dank, M., Boér, K., Pajkos, G., Faluhelyi, Z., Pikó, B., Eckhardt, S. & Horváth, Z., Sep 1 2010, In : Magyar Onkologia. 54, 3, p. 237-254 18 p.

Research output: Contribution to journalArticle

Hormonal Antineoplastic Agents
Local Neoplasm Recurrences
Antineoplastic Combined Chemotherapy Protocols
ErbB-2 Receptor
Cachexia
3 Citations (Scopus)

Az emlorák korszeru gyógyszeres kezelése

Translated title of the contribution: Modern pharmacological therapy of breast cancerLáng, I., Kahán, Z., Hitre, E., Dank, M., Rubovszky, G., Horváth, Z. & Kásler, M., Jan 1 2012, In : Orvosi Hetilap. 153, 2, p. 56-65 10 p.

Research output: Contribution to journalArticle

Pharmacology
Breast Neoplasms
Therapeutics
Neoplasms
Biological Therapy

Az emlorák korszeru képalkotó diagnosztikája: nukleárismedicina-technikák

Translated title of the contribution: Modern diagnostics of breast cancer: Nuclear medicine techniquesKatalin, B., István, S., Balázs, M., Horváth, Z., Láng, I. & Kásler, M., Jan 1 2012, In : Orvosi Hetilap. 153, 1, p. 14-21 8 p.

Research output: Contribution to journalArticle

Hungary
Nuclear Medicine
Breast Neoplasms
1 Citation (Scopus)

Az emlótumor csontveló mikrometasztázisának klinikai jelentósége.

Translated title of the contribution: Clinical significance of bone marrow micrometastases of breast tumorsDubecz, S., Csuka, O., Török, K., Vasas, N., Péley, G., Doleschal, Z., Sulyok, Z., Láng, I. & Köves, I., 2003, In : Magyar sebészet. 56, 3-4, p. 108-112 5 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Bone Marrow
Breast Neoplasms
Estrogen Receptors
Keratin-20

Az epeúti carcinomák gyógyszeres kezelé sének lehetõségei. Múlt - Jelen - Jóvo

Translated title of the contribution: Opportunities in drug therapy of biliary tract cancer. Past - Present - FutureGábor, R., Hitre, E. & Láng, I., 2013, In : Lege Artis Medicinae. 23, 5-6, p. 255-261 7 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Bile Duct Neoplasms
Drug Therapy
Gallbladder Neoplasms
Therapeutics
4 Citations (Scopus)

Az epidermális növekedési faktor recept orát célzó terápiák RAS paradoxona vastag- és végbélrákban

Translated title of the contribution: The RAS paradoxon of the EGFR-targeted therapy of colorectal cancerTímár, J. & Láng, I., 2008, In : Magyar Onkologia. 52, 2, p. 185-191 7 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Neoplasms
Anti-Idiotypic Antibodies
Adenoma

Az indometacin lymphocyta proliferációt fokozó hatása in vivo.

Translated title of the contribution: Lymphocyte proliferation-enhancing effect of indomethacin in vivoKalmár, L., Rhenzo, G. C., Láng, I., Gergely, P. & Fehér, J., Nov 24 1985, In : Orvosi Hetilap. 126, 47, p. 2889-2893 5 p.

Research output: Contribution to journalArticle

Leukocyte Count
Indomethacin
Lymphocytes
1 Citation (Scopus)

Az MR-vizsgálat szerepe a rectumcarcinomák terápiájának meghatározásában

Translated title of the contribution: Role of MRI in determining the therapy of rectal cancerJederán, É., Mátrai, Z., Tóth, L., Lövey, J., Láng, I., Hitre, E., Naszádos, G. & Godény, M., 2012, In : Magyar Onkologia. 56, 3, p. 179-186 8 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Endosonography
Neoadjuvant Therapy
Hungary
Neoplasm Staging
314 Citations (Scopus)

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): An open-label, randomised phase 3 trial

Cunningham, D., Láng, I., Marcuello, E., Lorusso, V., Ocvirk, J., Shin, D. B., Jonker, D., Osborne, S., Andre, N., Waterkamp, D. & Saunders, M. P., Oct 2013, In : The Lancet Oncology. 14, 11, p. 1077-1085 9 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
oxaliplatin
irinotecan
Disease-Free Survival
Poisons
89 Citations (Scopus)

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): An open-label, randomised phase 3 trial

von Minckwitz, G., Puglisi, F., Cortes, J., Vrdoljak, E., Marschner, N., Zielinski, C., Villanueva, C., Romieu, G., Láng, I., Ciruelos, E., De Laurentiis, M., Veyret, C., de Ducla, S., Freudensprung, U., Srock, S. & Gligorov, J., Oct 1 2014, In : The Lancet Oncology. 15, 11, p. 1269-1278 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Disease-Free Survival
Therapeutics
Random Allocation